J. Joseph Kim
2017
In 2017, J. Joseph Kim earned a total compensation of $4.4M as President, Chief Executive Officer and Director at Inovio Pharmaceuticals, a 48% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $353,600 |
---|---|
Option Awards | $188,818 |
Salary | $780,007 |
Stock Awards | $3,051,725 |
Other | $15,118 |
Total | $4,389,268 |
Kim received $3.1M in stock awards, accounting for 70% of the total pay in 2017.
Kim also received $353.6K in non-equity incentive plan, $188.8K in option awards, $780K in salary and $15.1K in other compensation.
Rankings
In 2017, J. Joseph Kim's compensation ranked 2,276th out of 14,666 executives tracked by ExecPay. In other words, Kim earned more than 84.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,276 | 85th |
Manufacturing | 793 | 86th |
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 102 | 88th |
Surgical, Medical, And Dental Instruments And Supplies | 52 | 90th |
Surgical and Medical Instruments and Apparatus | 32 | 91st |
Kim's colleagues
We found three more compensation records of executives who worked with J. Joseph Kim at Inovio Pharmaceuticals in 2017.
News
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021
Inovio Pharmaceuticals CEO J Kim's 2018 pay falls 30% to $3.1M
March 25, 2019